Aki T. Heikkinen

Aki T. Heikkinen

Auto-generated profile, based on publicly available information

Aki T. Heikkinen

Department of Pharmaceutics, University of Kuopio, Kuopio, Finland

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2009 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
TKTimo Korjamo
Timo Korjamo
AHAki T. Heikkinen
Aki T. Heikkinen
JMJukka Mönkkönen
Jukka Mönkkönen

1 September 2012 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
AHAki T. Heikkinen
Aki T. Heikkinen
GBGuillaume Baneyx
Guillaume Baneyx
ACAntonello Caruso
Antonello Caruso
NPNeil Parrott
Neil Parrott

16 April 2008 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
TKTimo Korjamo
Timo Korjamo
AHAki T. Heikkinen
Aki T. Heikkinen
PWPekka Waltari
Pekka Waltari
JMJukka Mönkkönen
Jukka Mönkkönen

1 February 2009 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
EAEva Maria del Amo
Eva Maria del Amo
AHAki T. Heikkinen
Aki T. Heikkinen
JMJukka Mönkkönen
Jukka Mönkkönen

1 March 2009 in Placenta
Verified
Journal Article
Closed access
KAK. Annola
K. Annola
AHA.T. Heikkinen
A.T. Heikkinen
HPH. Partanen
H. Partanen
HWH. Woodhouse
H. Woodhouse
DSD. Segerbäck
D. Segerbäck
KVK. Vähäkangas
K. Vähäkangas

1 September 2007 in Drug Metabolism and Disposition
Verified
Journal Article
Closed access
PDF file
TKTimo Korjamo
Timo Korjamo
HKHeidi Kemiläinen
Heidi Kemiläinen
AHAki T. Heikkinen
Aki T. Heikkinen
JMJukka Mönkkönen
Jukka Mönkkönen
Passive permeability and active efflux are parallel processes in transcellular flux. Therefore, the observed kinetics of a transporter substrate depends on both of these factors. The transporter expression has been shown to affect both the apparent Km and Vmax values. Kinetic parameters can be obtained from various experimental settings, but these do not necessarily reflect the situation in transcellular flux. Kinetic absorption models need reliable estimates of saturable kinetics when accurate in silico predictions are to be made. The effect of increasing P-glycoprotein expression on apparent transport kinetics was studied using quinidine and digoxin as model compounds. The intracellular concentrations of drugs during the transport process were also measured. A dynamic simulation model was constructed to study the observed data. The apparent Km and Vmax values increased as the P-glycoprotein expression increased. Simulations reproduced the shift in both kinetic parameters as a function of efflux pump expression. In addition, the apparent Km value showed a strong inverse relationship to the passive permeability. In contrast, the apparent Vmax value reached a maximum at intermediate passive permeability and declined above and below this passive permeability. The true Vmax and Km values were never reached. The shift in Km was assigned to a decrease in intracellular concentration at the P-glycoprotein interaction site with both experimental and simulation data. In conclusion, the apparent kinetic parameters in transcellular permeability assays depend on passive permeability and efflux pump activity. Therefore, parameters that are obtained from in vitro assays should be cautiously applied to in vivo predictions.